Ridhi Tariyal, BS, Georgia Tech; MBA, Harvard University; SM, MIT; Blavatnik Fellow; Ferolyn Fellow, is CEO and co-Founder of NextGen Jane. At NextGen Jane, Ridhi has driven the development of a novel menstrual data platform characterizing uterine biology at a molecular level. In this effort, she has raised capital, established an IP position, and developed a team to create both novel hardware and software to change how women access care. Before NGJ, Ridhi worked at the Broad Institute and at Bristol Myers Squibb.
